# Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma

> **NCT00805896** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 260 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Unresectable

## Interventions

- **DRUG:** Songyou
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00805896
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2008-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805896, "Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00805896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*